LYCIA THERAPEUTICS Trademark

Trademark Overview


On Thursday, September 11, 2025, a trademark application was filed for LYCIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LYCIA THERAPEUTICS trademark a serial number of 99387673. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 24, 2026. This trademark is owned by Lycia Therapeutics, Inc.. The LYCIA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therape...
lycia therapeutics

General Information


Serial Number99387673
Word MarkLYCIA THERAPEUTICS
Filing DateThursday, September 11, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, February 24, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2026

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 11, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLycia Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US

Party NameLycia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US

Trademark Events


Event DateEvent Description
Thursday, September 11, 2025NEW APPLICATION ENTERED
Thursday, September 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 11, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 23, 2026ASSIGNED TO EXAMINER
Friday, January 23, 2026NON-FINAL ACTION WRITTEN
Friday, January 23, 2026NON-FINAL ACTION E-MAILED
Friday, January 23, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 30, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 30, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 30, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 31, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 18, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 24, 2026PUBLISHED FOR OPPOSITION
Tuesday, February 24, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED